{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:00:02Z","timestamp":1791734402652,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32222046 and 82172630"],"award-info":[{"award-number":["32222046 and 82172630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite the significant potential of photodynamic therapy (PDT) in cancer treatment, further refinement is needed to address challenges such as poor tumor-specific accumulation of photosensitizers and the development of therapeutic resistance, which may be regulated by epigenetics. Here, a novel tumor microenvironment-responsive delivery platform was developed to co-deliver epigenetic protein degraders and photosensitizers, aiming to block the relevant regulatory mechanisms and enhance the effectiveness of combination therapy. Benefiting from the targeting ability, pH-triggered charge reversal, and intracellular glutathione (GSH)-responsive release, the delivery platform exhibited enhanced tumor accumulation and therapeutic effects. The mechanism of action revealed that the precise accumulation and release of drugs via the tumor-orchestrated delivery system not only regulated cell growth and immune activation, but also inhibited the expression of tumor immune escape molecules (PDL1 and CD47) and M2 macrophage polarization, significantly increasing the anti-breast cancer and anti-melanoma effects of PDT in the presence of an epigenetic modifier. More importantly, we found for the first time that photodynamic therapy can generate therapeutic resistance through the upregulation of CCL5, and confirmed that this resistance can be reduced by the epigenetic degradation of bromodomain-containing protein 4 (BRD4). These findings underscore the potential of integrating PDT with epigenetic protein degraders through a programmed delivery platform, offering a promising strategy for improving cancer treatment outcomes.<\/jats:p>","DOI":"10.1038\/s41392-025-02542-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:02:20Z","timestamp":1769731340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform"],"prefix":"10.1038","volume":"11","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-5072","authenticated-orcid":false,"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2542_CR1","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1001\/jama.2024.4840","volume":"331","author":"WY Chen","year":"2024","unstructured":"Chen, W. Y. et al. Aspirin vs placebo as adjuvant therapy for breast cancer: the Alliance A011502 randomized trial. JAMA 331, 1714\u20131721 (2024).","journal-title":"JAMA"},{"key":"2542_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","volume":"15","author":"JG Hiller","year":"2018","unstructured":"Hiller, J. G. et al. Perioperative events influence cancer recurrence risk after surgery. Nat. Rev. Clin. Oncol. 15, 205\u2013218 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2542_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","volume":"17","author":"TI Yock","year":"2016","unstructured":"Yock, T. I. et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 17, 287\u2013298 (2016).","journal-title":"Lancet Oncol."},{"key":"2542_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrc1071","volume":"3","author":"DEJGJ Dolmans","year":"2003","unstructured":"Dolmans, D. E. J. G. J., Fukumura, D. & Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380\u2013387 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"2542_CR5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/nm.2933","volume":"18","author":"NM Idris","year":"2012","unstructured":"Idris, N. M. et al. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 18, 1580\u20131585 (2012).","journal-title":"Nat. Med."},{"key":"2542_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi1965","volume":"9","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Genotype-specific precision tumor therapy using mitochondrial DNA mutation-induced drug release system. Sci. Adv. 9, eadi1965 (2023).","journal-title":"Sci. Adv."},{"key":"2542_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17, 657\u2013674 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2542_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310875","volume":"36","author":"L Li","year":"2024","unstructured":"Li, L. et al. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor. Adv. Mater. 36, e2310875 (2024).","journal-title":"Adv. Mater."},{"key":"2542_CR9","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1039\/D0CS01370F","volume":"50","author":"J Xie","year":"2021","unstructured":"Xie, J. et al. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies. Chem. Soc. Rev. 50, 9152\u20139201 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"2542_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303911","volume":"13","author":"Y Tai","year":"2024","unstructured":"Tai, Y. et al. MOF@COF nanocapsules enhance soft tissue sarcoma treatment: synergistic effects of photodynamic therapy and PARP inhibition on tumor growth suppression and immune response activation. Adv. Healthc. Mater. 13, e2303911 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"2542_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200898","volume":"7","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Blocking cholesterol metabolism with tumor-penetrable nanovesicles to improve photodynamic cancer immunotherapy. Small Methods 7, e2200898 (2023).","journal-title":"Small Methods"},{"key":"2542_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309534","volume":"36","author":"N Song","year":"2024","unstructured":"Song, N. et al. A DNA\/upconversion nanoparticle complex enables controlled co-delivery of CRISPR-Cas9 and photodynamic agents for synergistic cancer therapy. Adv. Mater. 36, e2309534 (2024).","journal-title":"Adv. Mater."},{"key":"2542_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell 41, 1294\u20131308.e1298 (2023).","journal-title":"Cancer Cell"},{"key":"2542_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature09803","volume":"471","author":"T Robert","year":"2011","unstructured":"Robert, T. et al. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 471, 74\u201379 (2011).","journal-title":"Nature"},{"key":"2542_CR15","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","volume":"187","author":"J Yu","year":"2024","unstructured":"Yu, J. et al. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. Cell 187, 4713\u20134732.e4719 (2024).","journal-title":"Cell"},{"key":"2542_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-020-2168-1","volume":"580","author":"RJ Deshaies","year":"2020","unstructured":"Deshaies, R. J. Multispecific drugs herald a new era of biopharmaceutical innovation. Nature 580, 329\u2013338 (2020).","journal-title":"Nature"},{"key":"2542_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.2329","volume":"13","author":"MS Gadd","year":"2017","unstructured":"Gadd, M. S. et al. Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat. Chem. Biol. 13, 514\u2013521 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2542_CR18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.apsb.2022.02.009","volume":"12","author":"T Yang","year":"2022","unstructured":"Yang, T. et al. A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization. Acta Pharm. Sin. B 12, 2658\u20132671 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"2542_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409753","volume":"11","author":"L Yi","year":"2024","unstructured":"Yi, L. et al. BRD4 degradation enhanced glioma sensitivity to temozolomide by regulating Notch1 via glu-modified GSH-responsive nanoparticles. Adv. Sci. 11, e2409753 (2024).","journal-title":"Adv. Sci."},{"key":"2542_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2542_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nchem.2811","volume":"9","author":"HD Herce","year":"2017","unstructured":"Herce, H. D. et al. Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells. Nat. Chem. 9, 762\u2013771 (2017).","journal-title":"Nat. Chem."},{"key":"2542_CR22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nmat4707","volume":"15","author":"J Conde","year":"2016","unstructured":"Conde, J., Oliva, N., Zhang, Y. & Artzi, N. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat. Mater. 15, 1128\u20131138 (2016).","journal-title":"Nat. Mater."},{"key":"2542_CR23","doi-asserted-by":"publisher","first-page":"1707249","DOI":"10.1002\/adfm.201707249","volume":"28","author":"L Dai","year":"2018","unstructured":"Dai, L. et al. Size\/charge changeable acidity-responsive micelleplex for photodynamic-improved PD-L1 immunotherapy with enhanced tumor penetration. Adv. Funct. Mater. 28, 1707249 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"2542_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404296","volume":"36","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Smart nanoassembly enabling activatable NIR fluorescence and ROS generation with enhanced tumor penetration for imaging-guided photodynamic therapy. Adv. Mater. 36, e2404296 (2024).","journal-title":"Adv. Mater."},{"key":"2542_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2018.06.012","volume":"284","author":"Y Han","year":"2018","unstructured":"Han, Y. et al. Oxygen-independent combined photothermal\/photodynamic therapy delivered by tumor acidity-responsive polymeric micelles. J. Control. Release 284, 15\u201325 (2018).","journal-title":"J. Control. Release"},{"key":"2542_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120194","volume":"255","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy. Biomaterials 255, 120194 (2020).","journal-title":"Biomaterials"},{"key":"2542_CR27","doi-asserted-by":"publisher","first-page":"10456","DOI":"10.1002\/anie.202002748","volume":"59","author":"J Gao","year":"2020","unstructured":"Gao, J. et al. Cellular AND gates: synergistic recognition to boost selective uptake of polymeric nanoassemblies. Angew. Chem. Int. Ed. 59, 10456\u201310460 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2542_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/s41565-024-01757-4","volume":"19","author":"D-T Nguyen","year":"2024","unstructured":"Nguyen, D.-T. et al. Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics. Nat. Nanotechnol. 19, 1723\u20131734 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2542_CR29","doi-asserted-by":"publisher","first-page":"1606628","DOI":"10.1002\/adma.201606628","volume":"29","author":"Q Sun","year":"2017","unstructured":"Sun, Q., Zhou, Z., Qiu, N. & Shen, Y. Rational design of cancer nanomedicine: nanoproperty integration and synchronization. Adv. Mater. 29, 1606628 (2017).","journal-title":"Adv. Mater."},{"key":"2542_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.apsb.2022.05.011","volume":"13","author":"L Geng","year":"2023","unstructured":"Geng, L. et al. Iron-based and BRD4-downregulated strategy for amplified ferroptosis based on pH-sensitive\/NIR-II-boosted nano-matchbox. Acta Pharm. Sin. B 13, 863\u2013878 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2542_CR31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1158\/0008-5472.CAN-23-1749","volume":"84","author":"X Zhu","year":"2024","unstructured":"Zhu, X. et al. Cotargeting CDK4\/6 and BRD4 promotes senescence and ferroptosis sensitivity in cancer. Cancer Res. 84, 1333\u20131351 (2024).","journal-title":"Cancer Res."},{"key":"2542_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi, L. et al. Targeting immunogenic cell stress and death for cancer therapy. Nat. Rev. Drug Discov. 23, 445\u2013460 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2542_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","volume":"1","author":"SA Oh","year":"2020","unstructured":"Oh, S. A. et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat. Cancer 1, 681\u2013691 (2020).","journal-title":"Nat. Cancer"},{"key":"2542_CR34","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1016\/j.ymthe.2022.07.022","volume":"30","author":"M Zhang","year":"2022","unstructured":"Zhang, M. et al. BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma. Mol. Ther. 30, 3394\u20133413 (2022).","journal-title":"Mol. Ther."},{"key":"2542_CR35","doi-asserted-by":"publisher","first-page":"109661","DOI":"10.1016\/j.intimp.2022.109661","volume":"115","author":"TT Yu","year":"2023","unstructured":"Yu, T. T. et al. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage. Int. Immunopharmacol. 115, 109661 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2542_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","volume":"5","author":"C Huang","year":"2024","unstructured":"Huang, C. et al. Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nat. Cancer 5, 500\u2013516 (2024).","journal-title":"Nat. Cancer"},{"key":"2542_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46778-8","volume":"15","author":"F Reggiani","year":"2024","unstructured":"Reggiani, F. et al. BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3. Nat. Commun. 15, 2567 (2024).","journal-title":"Nat. Commun."},{"key":"2542_CR38","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/s41556-024-01478-9","volume":"26","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Lymphotoxin-\u03b2 promotes breast cancer bone metastasis colonization and osteolytic outgrowth. Nat. Cell Biol. 26, 1597\u20131612 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2542_CR39","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway. Cell Death Differ. 27, 1765\u20131781 (2020).","journal-title":"Cell Death Differ."},{"key":"2542_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","volume":"163","author":"A Serrels","year":"2015","unstructured":"Serrels, A. et al. Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity. Cell 163, 160\u2013173 (2015).","journal-title":"Cell"},{"key":"2542_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","volume":"21","author":"RJ Slack","year":"2022","unstructured":"Slack, R. J. et al. Emerging therapeutic opportunities for integrin inhibitors. Nat. Rev. Drug Discov. 21, 60\u201378 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2542_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42740-2","volume":"14","author":"J Yan","year":"2023","unstructured":"Yan, J. et al. An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer. Nat. Commun. 14, 6905 (2023).","journal-title":"Nat. Commun."},{"key":"2542_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103\u2013126 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"2542_CR44","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1021\/acsnano.1c10231","volume":"16","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy. ACS Nano 16, 4228\u20134238 (2022).","journal-title":"ACS Nano"},{"key":"2542_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202402720","volume":"36","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Expanded ROS generation and hypoxia reversal: excipient-free self-assembled nanotheranostics for enhanced cancer photodynamic immunotherapy. Adv. Mater. 36, e2402720 (2024).","journal-title":"Adv. Mater."},{"key":"2542_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc1894","volume":"6","author":"AP Castano","year":"2006","unstructured":"Castano, A. P., Mroz, P. & Hamblin, M. R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6, 535\u2013545 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"2542_CR47","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jid.2022.12.018","volume":"143","author":"OA Oyebanji","year":"2023","unstructured":"Oyebanji, O. A. et al. Topical photodynamic therapy generates bioactive microvesicle particles: evidence for a pathway involved in immunosuppressive effects. J. Invest. Dermatol. 143, 1279\u20131288 (2023).","journal-title":"J. Invest. Dermatol."},{"key":"2542_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Immunogenic cell stress and death. Nat. Immunol. 23, 487\u2013500 (2022).","journal-title":"Nat. Immunol."},{"key":"2542_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L. et al. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2542_CR50","doi-asserted-by":"publisher","first-page":"2214499","DOI":"10.1002\/adfm.202214499","volume":"33","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. A microenvironment dual-responsive nano-drug equipped with PD-L1 blocking peptide triggers immunogenic pyroptosis for prostate cancer self-synergistic immunotherapy. Adv. Funct. Mater. 33, 2214499 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"2542_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01464-x","volume":"20","author":"E Dai","year":"2021","unstructured":"Dai, E. et al. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol. Cancer 20, 171 (2021).","journal-title":"Mol. Cancer"},{"key":"2542_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-021-00431-4","volume":"22","author":"AVR Kornepati","year":"2022","unstructured":"Kornepati, A. V. R., Vadlamudi, R. K. & Curiel, T. J. Programmed death ligand 1 signals in cancer cells. Nat. Rev. Cancer 22, 174\u2013189 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2542_CR53","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg, M. E. W., Scheeren, F. A. & Schumacher, T. N. The CD47-SIRP\u03b1 immune checkpoint. Immunity 52, 742\u2013752 (2020).","journal-title":"Immunity"},{"key":"2542_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15290-0","volume":"11","author":"M Yin","year":"2020","unstructured":"Yin, M. et al. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nat. Commun. 11, 1833 (2020).","journal-title":"Nat. Commun."},{"key":"2542_CR55","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1172\/JCI86437","volume":"126","author":"Y Kagoya","year":"2016","unstructured":"Kagoya, Y. et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J. Clin. Invest. 126, 3479\u20133494 (2016).","journal-title":"J. Clin. Invest."},{"key":"2542_CR56","doi-asserted-by":"publisher","first-page":"2314203","DOI":"10.1002\/adfm.202314203","volume":"34","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Synergizing CXCL9 with BRD4-PROTAC using nanochaperone boosts robust T cell-dependent antitumor immune responses for cancer immunotherapy. Adv. Funct. Mater. 34, 2314203 (2024).","journal-title":"Adv. Funct. Mater."},{"key":"2542_CR57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","volume":"35","author":"D Dangaj","year":"2019","unstructured":"Dangaj, D. et al. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell 35, 885\u2013900 (2019).","journal-title":"Cancer Cell"},{"key":"2542_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15375-w","volume":"11","author":"W Seo","year":"2020","unstructured":"Seo, W. et al. Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity. Nat. Commun. 11, 1562 (2020).","journal-title":"Nat. Commun."},{"key":"2542_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/cmi.2012.69","volume":"10","author":"D Lv","year":"2013","unstructured":"Lv, D. et al. CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell. Mol. Immunol. 10, 303\u2013310 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"2542_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell 42, 885\u2013903 (2024).","journal-title":"Cancer Cell"},{"key":"2542_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400611","volume":"11","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. CD147-K148me2-driven tumor cell-macrophage crosstalk provokes NSCLC immunosuppression via the CCL5\/CCR5 axis. Adv. Sci. 11, e2400611 (2024).","journal-title":"Adv. Sci."},{"key":"2542_CR62","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41418-020-00626-6","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma. Cell Death Differ. 28, 932\u2013951 (2021).","journal-title":"Cell Death Differ."},{"key":"2542_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan8355","volume":"10","author":"B Serrels","year":"2017","unstructured":"Serrels, B. et al. IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks. Sci. Signal. 10, eaan8355 (2017).","journal-title":"Sci. Signal."},{"key":"2542_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38578-3","volume":"14","author":"T Tang","year":"2023","unstructured":"Tang, T. et al. Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner. Nat. Commun. 14, 3364 (2023).","journal-title":"Nat. Commun."},{"key":"2542_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103136","volume":"104","author":"S Shahmoradi Ghahe","year":"2021","unstructured":"Shahmoradi Ghahe, S. et al. Increased DNA repair capacity augments resistance of glioblastoma cells to photodynamic therapy. DNA Repair 104, 103136 (2021).","journal-title":"DNA Repair"},{"key":"2542_CR66","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4161\/auto.28679","volume":"10","author":"MF Wei","year":"2014","unstructured":"Wei, M. F. et al. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy 10, 1179\u20131192 (2014).","journal-title":"Autophagy"},{"key":"2542_CR67","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/ijms25063164","volume":"25","author":"W Udomsak","year":"2024","unstructured":"Udomsak, W. et al. Antioxidant enzymes in cancer cells: their role in photodynamic therapy resistance and potential as targets for improved treatment outcomes. Int. J. Mol. Sci. 25, 3164 (2024).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02542-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02542-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02542-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:02:21Z","timestamp":1769731341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02542-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02542-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}